tiprankstipranks
Advertisement
Advertisement
Hoth Therapeutics’ HT-VA shows cholesterol level restoration
PremiumThe FlyHoth Therapeutics’ HT-VA shows cholesterol level restoration
1M ago
Hoth Therapeutics announces expansion of CLEER-001 Phase 2a clinical trial
Premium
The Fly
Hoth Therapeutics announces expansion of CLEER-001 Phase 2a clinical trial
2M ago
Hoth Therapeutics receives U.S. notice of allowance for Exon-skipping therapy
Premium
The Fly
Hoth Therapeutics receives U.S. notice of allowance for Exon-skipping therapy
2M ago
Hoth Therapeutics highlights obesity and pipeline progress to regulators
PremiumCompany AnnouncementsHoth Therapeutics highlights obesity and pipeline progress to regulators
3M ago
Hoth Therapeutics expands oncology pipeline with dual patent filings
Premium
The Fly
Hoth Therapeutics expands oncology pipeline with dual patent filings
3M ago
Hoth Therapeutics accepted into Nvidia Connect Program
Premium
The Fly
Hoth Therapeutics accepted into Nvidia Connect Program
5M ago
Hoth Therapeutics selects Nvidia AI enterprise platform
PremiumThe FlyHoth Therapeutics selects Nvidia AI enterprise platform
6M ago
Hoth Therapeutics expands intellectual property portfolio for HT-001
Premium
The Fly
Hoth Therapeutics expands intellectual property portfolio for HT-001
7M ago
Hoth Therapeutics Faces Digital Asset Industry Challenges
Premium
Company Announcements
Hoth Therapeutics Faces Digital Asset Industry Challenges
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100